Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States

被引：8
|
作者：
Matsuo, Koji [1 ,2 ]
Klar, Maximilian [3 ]
Mandelbaum, Rachel S. [1 ]
Matsuzaki, Shinya [1 ]
Matsushima, Kazuhide [4 ]
Roman, Lynda D. [1 ,2 ]
Wright, Jason D. [5 ]
机构：
[1] Univ Southern Calif, Dept Obstet & Gynecol, Div Gynecol Oncol, 2020 Zonal Ave IRD520, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
[3] Univ Freiburg, Dept Obstet & Gynecol, Freiburg, Germany
[4] Univ Southern Calif, Dept Surg, Div Acute Care Surg, Los Angeles, CA 90007 USA
[5] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, New York, NY 10032 USA
来源：
ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 2020年 / 301卷 / 03期
关键词：
Ovarian cancer; Neoadjuvant chemotherapy; Interval debulking surgery; Minimally invasive surgery; Mortality; Outcome;
D O I：
10.1007/s00404-020-05442-4
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：863 / 866
页数：4
相关论文
共 50 条
  • [21] The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer
    Menderes, Gulden
    Black, Jonathan D.
    Azodi, Masoud
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 899 - 901
  • [22] Debulking Surgery in Advanced Epithelial Ovarian Cancer: Interval or at the End of Neoadjuvant Chemotherapy?
    F. Cantu-de Leon, D.
    Gallardo-Alvarado, L.
    Salcedo-Hernandez, R.
    Ramirez, R.
    Perez-Montiel, D.
    Onate-Ocana, L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S86 - S86
  • [23] Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Liu, Ying L.
    Zhou, Qin C.
    Iasonos, Alexia
    Filippova, Olga T.
    Chi, Dennis S.
    Zivanovic, Oliver
    Sonoda, Yukio
    Gardner, Ginger
    Broach, Vance
    OCearbhaill, Roisin
    Konner, Jason A.
    Aghajanian, Carol A.
    Long, Kara
    Tew, William
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (10) : 1554 - 1561
  • [24] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [25] Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer
    Nishio, Shin
    Ushijima, Kimio
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 379 - 386
  • [26] Interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer-retrospective study comparing surgery after 3 cycles or more of chemotherapy
    Bacry, Maureen Cohen
    Philippea, Anne Cecile
    Riethmuller, Didier
    Faucheron, Jean Luc
    Pomel, Christophe
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (07)
  • [27] Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis
    Zeng, Siyuan
    Yu, Yongai
    Cui, Yuemei
    Liu, Bing
    Jin, Xianyu
    Li, Zhengyan
    Liu, Lifeng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Interval from neoadjuvant chemotherapy to interval debulking surgery in advanced ovarian cancer: Is this a prognostic indicator?
    Hariprasad, R.
    Kumar, L.
    Mookerjee, A.
    Radhakrishnan, V.
    Kumar, S.
    Mathur, S.
    Thulkar, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer
    Zhou, Zhen Ni
    Chen, Ling
    Clair, Caryn S. T. .
    Hou, June
    Collado, Fady Khoury
    Gockley, Allison
    Melamed, Alexander
    Wright, Jason
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S230 - S230
  • [30] Factors that predict optimal debulking at interval cytoreductive surgery after neoadjuvant chemotherapy in epithelial ovarian cancer
    Boccaccio, R. B.
    Crim, A. K.
    Osborn, K.
    Ding, K.
    Moore, K. N.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 82 - 82
12345